|Videos|July 18, 2022
Metastasis Patterns of Basal Cell Carcinoma
Author(s)Jennifer L. Atlas, MD, Shahab Babakoohi, MD
A look at how common metastatic basal cell carcinoma is in clinical practice and when to consider frontline immunotherapy.
Advertisement
Advertisement
Related to this article
Adding intismeran autogene to pembrolizumab cut the risk of recurrence and distant metastasis in resected high-risk melanoma in INTerpath-001.
Phase 1 data support continued investigation of roginolisib in advanced cancers, including metastatic uveal melanoma.
Advertisement
Advertisement
Trending on OncLive
1
Petosemtamab Plus Pembrolizumab Hits Phase 3 OS, ORR Primary End Points in PD-L1+ R/M HNSCC
2
Breaking Down Key Lung Cancer Data at ESMO 2026 With Drs Santos and Halmos
3
Sac-TMT Plus Pembrolizumab Improves PFS in PD-L1–Negative Nonsquamous NSCLC
4
FDA Receives BLA for Etentamig in R/R Multiple Myeloma
5